Japan Lifeline Co. Ltd. Announces Organizational Restructuring, Abolishing Key Departments in R&D and Production Group

Reuters
06-26
Japan Lifeline Co. Ltd. Announces Organizational Restructuring, Abolishing Key Departments in R&D and Production Group

Japan Lifeline Co., Ltd., a prominent medical device company, has announced a corporate reorganization set to take effect on July 1, 2025. The company's Board of Directors resolved to abolish the Global OEM Initiative Office within the R&D and Production Group, along with the Production Control and Procurement Departments of the Supply Chain Division. Despite these changes, the functions of the Production Control and Procurement Departments will continue to be managed by the Supply Chain Division. This restructuring aims to streamline operations and enhance efficiency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JLL - Japan Lifeline Co. Ltd. published the original content used to generate this news brief on June 26, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10